Hypertension in transgender individuals View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-07-13

AUTHORS

Michael S. Irwig

ABSTRACT

Although there has been a dramatic increase in visibility and recognition of transgender and gender-diverse populations, remarkably little has been published on prevalence rates of hypertension within these populations. In addition to summarizing the limited data on prevalence rates, this review compares the prevalence rates with those of cisgender populations and explores whether gender-affirming hormone therapy affects blood pressure and hypertension rates. The studies show that hypertension affects a significant proportion of transgender and gender-diverse people and support the practice of routinely monitoring blood pressure in transgender and gender-diverse people, especially after the initiation of gender-affirming hormone therapy. The two largest studies both found that estrogen plus an antiandrogen was associated with a decrease in systolic blood pressure and that testosterone was associated with an increase in systolic blood pressure. More... »

PAGES

1-5

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41371-022-00721-w

DOI

http://dx.doi.org/10.1038/s41371-022-00721-w

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1149435688

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35831512


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Harvard Medical School, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA", 
            "Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Irwig", 
        "givenName": "Michael S.", 
        "id": "sg:person.01361524612.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361524612.43"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/s41366-021-00935-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1140443532", 
          "https://doi.org/10.1038/s41366-021-00935-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-07-13", 
    "datePublishedReg": "2022-07-13", 
    "description": "Although there has been a dramatic increase in visibility and recognition of transgender and gender-diverse populations, remarkably little has been published on prevalence rates of hypertension within these populations. In addition to summarizing the limited data on prevalence rates, this review compares the prevalence rates with those of cisgender populations and explores whether gender-affirming hormone therapy affects blood pressure and hypertension rates. The studies show that hypertension affects a significant proportion of transgender and gender-diverse people and support the practice of routinely monitoring blood pressure in transgender and gender-diverse people, especially after the initiation of gender-affirming hormone therapy. The two largest studies both found that estrogen plus an antiandrogen was associated with a decrease in systolic blood pressure and that testosterone was associated with an increase in systolic blood pressure.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41371-022-00721-w", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1098658", 
        "issn": [
          "0950-9240", 
          "1476-5527"
        ], 
        "name": "Journal of Human Hypertension", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "gender-affirming hormone therapy", 
      "systolic blood pressure", 
      "blood pressure", 
      "prevalence rates", 
      "hormone therapy", 
      "gender diverse people", 
      "hypertension rates", 
      "hypertension", 
      "larger study", 
      "cisgender population", 
      "gender diverse populations", 
      "limited data", 
      "therapy", 
      "significant proportion", 
      "transgender individuals", 
      "population", 
      "antiandrogens", 
      "estrogen", 
      "testosterone", 
      "dramatic increase", 
      "rate", 
      "pressure", 
      "study", 
      "transgender", 
      "increase", 
      "review", 
      "people", 
      "initiation", 
      "proportion", 
      "individuals", 
      "decrease", 
      "practice", 
      "addition", 
      "data", 
      "recognition", 
      "visibility", 
      "explores"
    ], 
    "name": "Hypertension in transgender individuals", 
    "pagination": "1-5", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1149435688"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41371-022-00721-w"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35831512"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41371-022-00721-w", 
      "https://app.dimensions.ai/details/publication/pub.1149435688"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_929.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41371-022-00721-w"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41371-022-00721-w'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41371-022-00721-w'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41371-022-00721-w'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41371-022-00721-w'


 

This table displays all metadata directly associated to this object as RDF triples.

97 TRIPLES      21 PREDICATES      61 URIs      52 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41371-022-00721-w schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Na1b6e0ba054d407290e0ed7c39eb31a0
4 schema:citation sg:pub.10.1038/s41366-021-00935-x
5 schema:datePublished 2022-07-13
6 schema:datePublishedReg 2022-07-13
7 schema:description Although there has been a dramatic increase in visibility and recognition of transgender and gender-diverse populations, remarkably little has been published on prevalence rates of hypertension within these populations. In addition to summarizing the limited data on prevalence rates, this review compares the prevalence rates with those of cisgender populations and explores whether gender-affirming hormone therapy affects blood pressure and hypertension rates. The studies show that hypertension affects a significant proportion of transgender and gender-diverse people and support the practice of routinely monitoring blood pressure in transgender and gender-diverse people, especially after the initiation of gender-affirming hormone therapy. The two largest studies both found that estrogen plus an antiandrogen was associated with a decrease in systolic blood pressure and that testosterone was associated with an increase in systolic blood pressure.
8 schema:genre article
9 schema:isAccessibleForFree false
10 schema:isPartOf sg:journal.1098658
11 schema:keywords addition
12 antiandrogens
13 blood pressure
14 cisgender population
15 data
16 decrease
17 dramatic increase
18 estrogen
19 explores
20 gender diverse people
21 gender diverse populations
22 gender-affirming hormone therapy
23 hormone therapy
24 hypertension
25 hypertension rates
26 increase
27 individuals
28 initiation
29 larger study
30 limited data
31 people
32 population
33 practice
34 pressure
35 prevalence rates
36 proportion
37 rate
38 recognition
39 review
40 significant proportion
41 study
42 systolic blood pressure
43 testosterone
44 therapy
45 transgender
46 transgender individuals
47 visibility
48 schema:name Hypertension in transgender individuals
49 schema:pagination 1-5
50 schema:productId N764f0722578c4cdc833984fa81f1c94c
51 Nbbb35ef7e3ae4e119aa8e5415119d7db
52 Ne9833091ab9440b99acba47e785d3d99
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1149435688
54 https://doi.org/10.1038/s41371-022-00721-w
55 schema:sdDatePublished 2022-09-02T16:07
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher N466b8c7ef250471e994c7012cdf9ec23
58 schema:url https://doi.org/10.1038/s41371-022-00721-w
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N466b8c7ef250471e994c7012cdf9ec23 schema:name Springer Nature - SN SciGraph project
63 rdf:type schema:Organization
64 N764f0722578c4cdc833984fa81f1c94c schema:name pubmed_id
65 schema:value 35831512
66 rdf:type schema:PropertyValue
67 Na1b6e0ba054d407290e0ed7c39eb31a0 rdf:first sg:person.01361524612.43
68 rdf:rest rdf:nil
69 Nbbb35ef7e3ae4e119aa8e5415119d7db schema:name doi
70 schema:value 10.1038/s41371-022-00721-w
71 rdf:type schema:PropertyValue
72 Ne9833091ab9440b99acba47e785d3d99 schema:name dimensions_id
73 schema:value pub.1149435688
74 rdf:type schema:PropertyValue
75 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
76 schema:name Medical and Health Sciences
77 rdf:type schema:DefinedTerm
78 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
79 schema:name Cardiorespiratory Medicine and Haematology
80 rdf:type schema:DefinedTerm
81 sg:journal.1098658 schema:issn 0950-9240
82 1476-5527
83 schema:name Journal of Human Hypertension
84 schema:publisher Springer Nature
85 rdf:type schema:Periodical
86 sg:person.01361524612.43 schema:affiliation grid-institutes:grid.38142.3c
87 schema:familyName Irwig
88 schema:givenName Michael S.
89 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361524612.43
90 rdf:type schema:Person
91 sg:pub.10.1038/s41366-021-00935-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1140443532
92 https://doi.org/10.1038/s41366-021-00935-x
93 rdf:type schema:CreativeWork
94 grid-institutes:grid.38142.3c schema:alternateName Harvard Medical School, Boston, MA, USA
95 schema:name Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA
96 Harvard Medical School, Boston, MA, USA
97 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...